Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

The process involves using specialised enzymes called restriction enzymes to cut the source DNA at desired sequences and isolate fragments of interest. DNA ligase, another enzyme, is then used to fuse ...

Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

DUBLIN, Nov. 22, 2023 /PRNewswire/ -- The "Global Recombinant DNA Technology Market Analysis & Forecast to 2023-2033: Market By Product; By End User; and By Region" report has been added to ...

The demand for the manufacturing of polypeptides has radically increased since the recent introduction of new diabetes, obesity and cardiovascular disease peptide drugs. Consequently, peptide API ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Marketresearch.biz reports that the Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 743.6 Bn in 2022, growing at a CAGR of 5.8% during the forecast ...